Schedule 13G ownership disclosure
OptimizeRx Corp
Common Stock · CUSIP: 68401U204
Event date: 2024-12-31
- Filing-level shares
- 1,069,560.00
- Percent of class
- 5.81%
- ROYCE & ASSOCIATES LP
Shares: 1,069,560.00 · Class: 5.81%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000906304-25-000035
- Form type
- SCHEDULE 13G
- Filer
- OptimizeRx Corp
- CIK
- CIK 1448431
- Filed
- Jan 28, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership